Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 106UNKNOWN 4NIH 3OTHER_GOV 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Uterine Cervical Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Cisplatin 48Capecitabine 41Gemcitabine 33apatinib 32Oxaliplatin 32Cyclophosphamide 31Radiotherapy 29Paclitaxel 29Carboplatin 29tislelizumab 27Irinotecan 27Drug Therapy 27Fluorouracil 26Docetaxel 26Bevacizumab 23fludarabine 18Nivolumab 17pembrolizumab 16Surgical Procedures, Operative 16Exercise 16Metformin 15S 1 (combination) 14camrelizumab 13Radiation 13Pemetrexed 13Control Groups 12anlotinib 11Leucovorin 11Vinorelbine 10Standard of Care 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × Radiation Dose Hypofractionation × Clear all
NCT05318274 2026-03-23

Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer.

Coordinación de Investigación en Salud, Mexico

Phase NA Active not recruiting
72 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT03750539 2023-11-14

Chemotherapy and Pelvic Hypofractionated Radiation Followed by Surgery Cervical Cancer

National Institute of Cancerología

Phase NA Unknown
100 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡